Skip to main content
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. — Investor Relations & Filings

Ticker · PRAX ISIN · US74006W2070 US Manufacturing
Open in API
Filings indexed 458 across all filing types
Latest filing 2023-04-06 Director's Dealing
Country US United States of America
Listing US PRAX

About Praxis Precision Medicines, Inc.

https://praxismedicines.com/

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company's methodology involves translating insights from genetic epilepsies into treatments for conditions characterized by neuronal excitation-inhibition imbalance. Praxis employs a genetics-focused approach, utilizing translational tools and patient-guided development strategies to advance its portfolio. The developmental pipeline includes several clinical-stage assets and numerous early-stage programs designed to address complex brain disorders.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2023-04-06 English
OWNERSHIP DOCUMENT
Director's Dealing
2023-03-27 English
OWNERSHIP DOCUMENT
Director's Dealing
2023-03-27 English
OWNERSHIP DOCUMENT
Director's Dealing
2023-03-27 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes the departure of a Chief Commercial Officer, details of a separation agreement, and a company update on priorities and cash runway. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The primary focus is on management changes and related agreements. Therefore, this fits the category of Board/Management Information (MANG). The document length is 6956 characters, which is sufficient to contain substantive information rather than a brief announcement. Hence, the classification is MANG with high confidence.
2023-03-21 English
SCHEDULE 13D
Major Shareholding Notification
2023-03-20 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.